[Federal Register: April 5, 2004 (Volume 69, Number 65)]
[Proposed Rules]
[Page 17615-17616]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05ap04-21]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
21 CFR Chapter I
[Docket No. 2004N-0115]
Prescription Drug Importation; Public Meeting and Establishment
of Docket; Extension of Deadline for Speakers To Submit Requests for
Presentations
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public meeting and establishment of docket; extension
of deadline to submit requests for presentations.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is extending to April
6, 2004, the deadline for speakers to submit requests for presentations
and a summary of the presentation at the April 14, 2004, public meeting
on prescription drug importation. This public meeting was announced in
the
[[Page 17616]]
Federal Register of March 18, 2004 (69 FR 12810).
DATES: Written requests for presentations and summaries of the
presentations must be submitted by April 6, 2004.
ADDRESSES: Submit a request for presentations and a summary of your
presentation to Karen Strambler, Office of Policy, Office of the
Commissioner, Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301-827-3360, e-mail: Karen.Strambler@fda.gov.
SUPPLEMENTARY INFORMATION: In the Federal Register of March 18, 2004
(69 FR 12810), FDA published a notice of public meeting and
establishment of docket announcing that it established a docket to
receive information and comments on certain issues related to the
importation of prescription drugs. FDA also announced a public meeting
to enable interested individuals, organizations, and other stakeholders
to present information to the Task Force for consideration in the study
on importation mandated by the Medicare Prescription Drug, Improvement
and Modernization Act of 2003. Speakers were asked to submit requests
for presentations along with a short summary of their presentation by
close of business on March 30, 2004. FDA is extending that deadline to
April 6, 2004.
All other information and requirements of the March 18, 2004,
Federal Register notice remain the same.
Dated: March 31, 2004.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 04-7714 Filed 4-1-04; 11:04 am]
BILLING CODE 4160-01-S